Trials / Completed
CompletedNCT00688142
Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder
Magnetoencephalographic Imaging of Sleepiness: The Effect of Armodafinil in Shift Work Sleep Disorder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- Henry Ford Health System · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The investigators hypothesize that in patients with shift work sleep disorder, armodafinil will specifically increase brain activity in the frontal cortex parallel with improvements in deficits of fundamental mechanisms of attention.
Detailed description
The current protocol will utilize a paradigm which is well suited to examine frontal attentional neuronal mechanisms by eliciting event related potential components known to reflect automatic stimulus detection as well as involuntary and voluntary attentional processes. The that end the proposed research has two specific aims. 1) Identify what areas of the frontal lobe and corresponding cognitive functions are impacted by excessive sleepiness in shift work sleep disorder and 2) identify specific brain areas affected by armodafinil and their role in improvement of fundamental attentional processes using a complex cognitive task targeting attentional control.
Conditions
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2008-06-02
- Last updated
- 2010-03-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00688142. Inclusion in this directory is not an endorsement.